KRAS and cancer: Supporting this, analysis from the cancer genome atlas dataset revealed that KRAS mutations were present in 45.5% of right-sided and 40.3% of left-sided colorectal cancers, while BRAF mutations occurred in 24.2% and 2.1% of cases, respectively (33).